Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

In Q2/25, Miner Achieves Positive Income For Fifth Straight Quarter

% of readers think this story is Fact. Add your two cents.


Source: Stuart McDougall 10/01/2025

Guanajuato Silver Co. Ltd.’s (GSVR:TSX.V; GSVRF:OTCQX) quarterly results, however, show the effects of lower throughput and grades, noted a Research Capital Corp. report.

Guanajuato Silver Co. (GSVR:TSX.V; GSVRF:OTCQX) released its Q2/25 operational and financial results, reported Stuart McDougall, Research Capital Corp. analyst, in a Sept. 2 research note. Research Capital raised its target price on the Canadian miner by 33%.

“At the mine level, this marks the fifth straight quarter in which the company has reported positive income since production began in Q4/21,” McDougall wrote.

40% Potential Upside

Research Capital’s new target price is CA$0.40 per share, up from CA$0.30. The increase reflects Guanajuato Silver’s lower share count since the investment firm’s last research report, when it expected the company to issue units in the August financing at half the actual price of CA$0.30 per unit.

“Our valuation still reflects an in situ approach, using US$3 per ounce silver and US$75 per ounce gold, discounted by 50% in the case of historic resources and adjusted for cash and equity,” McDougall explained.

Compared to the CA$0.40 per share target, Guanajuato Silver was trading at the time of the analyst’s research report at about CA$0.28 per share, implying a potential return of 40%.

The Vancouver, British Columbia-headquartered company that reactivates past-producing silver and gold mines in Mexico remains a Speculative Buy.

It has 543.4 million shares outstanding, a market cap of CA$154.88 million (CA$154.88M) and a 52-week range of CA$0.14–0.37 per share.

Overall Decline QOQ

McDougall reviewed Guanajuato Silver’s results from Q2/25, ended June 30, 2025, noting production and revenue declined since Q1/25. Production, down 15% from Q1/25, was 321,990 ounces of silver. This decrease resulted from both lower throughput and head grades due to having to rely on low-grade stockpiles. At the San Ignacio project, 94% of the material processed was fresh mineralization, at the El Cubo project 56% and at the Valenciana project 45%. Average consolidated recoveries of 83% stayed the same.

Production improved quarter over quarter (QOQ) at San Ignacio, El Cubo and Topia, and this offset losses at Valenciana, where mining focused on the 390 level at Cata and the 160 level at Pozos.

Financially, the precious metals miner reported a net loss in Q2/25 of US$3.7M. Operating cash flow from operations was positive at US$2.2M, due to strong metal prices.

McDougall wrote that throughput levels, grades and cash costs should improve in H2/25 and into next year as the producer invests capital in its mines. It has the funds to do so, having raised CA$18M through a nonbrokered equity financing in August.

According to the company, in Q2/25, its average cash cost was US$21.67 per silver equivalent ounce, its average all-in sustaining cost was US$26.38. Research Capital’s calculations, incorporating offsite costs and using the miner’s conversion ratios, are US$27.83 and US$32.97, respectively. Both are 15% higher QOQ, again largely reflecting the decline in throughput and grades.

At quarter’s end, Guanajuato Silver had US$1.9M in cash. It had (US$6.7M) in working capital, greatly improved from Q1/25 thanks to restructuring of its gold loan in April. Debt was US$18M.

Mine Development Advancing

McDougall reported the developmental changes Guanajuato has in progress or recently done at each of its four projects.

At El Cubo, dewatering of the lower levels in the Villalpando area and electrification are underway. Block 18-150 is expected to be ready for production in Q3/25. Electrification is expected to be done by year-end, eliminating the use of more expensive portable diesel generators.

At Valenciana, pumps and associated infrastructure were installed, and the 460 and 480 levels should be accessible by year-end.

At San Ignacio, the 442 Ramp was advanced, with access to Block 627 and Melladito Sur expected in Q3/25. Ramp 605 was advanced enough to intersect the Melladito Norte vein. Also, 65 meters of development were completed toward the vein’s north end in preparation for long-hole stoping in H2/25.

At Topia, the lead concentrate filter was commissioned and a new reagent storage facility was constructed. Commissioning of the zinc concentrate filter and newly installed centrifugal concentrator is expected by year-end. These programs are part of a phased approach to modernize and expand the flotation plant to 400 tons per day (400 tpd) from the current 260 tpd capacity.

What to Watch For

McDougall pointed out that near-term catalysts include project updates on an ongoing basis and subsequent quarterly results.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. Doresa Banning wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor.
  2. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Disclosures for Research Capital Corp., Guanajuato Silver Co., September 2, 2025

Analyst Certification I, Stuart McDougall, certify the views expressed in this report were formed by my review of relevant company data and industry investigation, and accurately reflect my opinion about the investment merits of the securities mentioned in the report. I also certify that my compensation is not related to specific recommendations or views expressed in this report. Each analyst of Research Capital Corporation whose name appears in this report hereby certifies that (i) the recommendations and opinions expressed in this research report accurately reflect the analyst’s personal views and (ii) no part of the research analyst’s compensation was or will be directly or indirectly related to the specific conclusions or recommendations expressed in this research report. Relevant Disclosures Applicable to Companies Under Coverage Information about Research Capital Corporation’s Rating System, the distribution of our research to clients and the percentage of recommendations which are in each of our rating catergories is available on our website at www.researchcapital.ca General Disclosures Research Capital Corporation publishes research and investment recommendations for the use of its clients. The opinions, estimates and projections contained in all Research Reports published by Research Capital Corporation (“RCC”) are those of RCC as of the date of publication and are subject to change without notice. RCC makes every effort to ensure that the contents have been compiled or derived from sources believed to be reliable and that contain information and opinions that are accurate and complete; RCC makes no representation or warranty, express or implied, in respect thereof, takes no responsibility for any errors and omissions which may be contained therein and accepts no liability whatsoever for any loss arising from any use of or reliance on its Research Reports or its contents. Information may be available to RCC that is not contained therein. Contents of this report cannot be reproduced in whole or in part without the express permission of Research Capital Corporation. Research Reports disseminated by RCC are not a solicitation to buy or sell. All securities not available in all jurisdictions. Distribution Policy Through www.researchcapital.com, our institutional and corporate clients can access our research as soon as it becomes available, 24-7. New reports are continually uploaded to the site as they become available throughout the day. Clients may also receive our research via Reuters, Bloomberg, FactSet, and Capital IQ. All of our research is made widely available at the same time to all Research Capital client groups entitled to our research. In addition, research reports are sent directly to our clients based on their delivery preference (mail, fax, e-mail). Fair Dissemination of Research Reports and Ratings To the extent reasonably practicable, Research Reports will be disseminated contemporaneously to all of Research Capital Corporation (“RCC”) customers who are entitled to receive the firm’s research. Until such time, Research Analysts will not discuss the contents of their reports with Sales and Trading or Investment Banking employees. RCC equity research is posted to our proprietary website to ensure eligible clients receive coverage initiations and changes in rating, targets and opinions in a timely manner. Additional distribution may be done by the sales personnel via email, fax or regular mail. Please contact your Investment Advisor or Portfolio Manager for more information regarding RCC research. Percentage Distribution of Research Ratings As required by the Canadian Investment Regulatory Organization, Research Capital provides a summary of the percentage of its recommendations that fall into each category of our ratings. Our distribution of ratings is available on our website at www.researchcapital.com Information regarding our categories of recommendations, quarterly summaries of the percentage of our recommendations which fall into each category and our policies regarding the release of our research reports is available at www.researchcapital.com or may be requested by contacting the analyst. Potential Conflicts of Interest All Research Capital Corporation (“RCC”) Analysts are compensated based in part on the overall revenues of RCC, a portion of which are generated by investment banking activities. RCC may have had, or seek to have, an investment banking relationship with companies mentioned in this report. RCC and/or its officers, directors and employees may from time to time acquire, hold or sell securities mentioned in our Research Reports as principal or agent. RCC makes every effort possible to avoid conflicts of interest, however readers should assume that a conflict might exist, and therefore not rely solely on this report when evaluating whether or not to buy or sell the securities of subject companies. Research Capital Corporation, its directors, officers and other employees may, from time to time, have positions in the securities mentioned herein. RC USA INC. US Institutional Clients – Research Capital USA Inc., a wholly owned subsidiary of Research Capital Corporation, accepts responsibility for the contents of this report. This report has been created by analysts who are employed by Research Capital Corporation, a Canadian Investment Dealer. US firms or institutions receiving this report should effect transactions in securities discussed in the report through Research Capital USA Inc., a Broker – Dealer registered with the Financial Industry Regulatory Authority (FINRA). Member – Canadian Investor Protection Fund / membre – fonds canadien de protection des épargnants

( Companies Mentioned: GSVR:TSX.V; GSVRF:OTCQX, )


Source: https://www.streetwisereports.com/article/2025/10/01/in-q2-25-miner-achieves-positive-income-for-fifth-straight-quarter.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login